Caxton Associates (New York)’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $590K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.03M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.45M | Buy |
|
|||||
|
2023
Q3 | $668K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.19M | Buy |
|
|||||
|
2022
Q3 | $342K | Sell |
|
|||||
|
2022
Q2 | $647K | Buy |
|
|||||
|
2022
Q1 | $311K | Sell |
|
|||||
|
2021
Q4 | $515K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $795K | Buy |
|
|||||
|
2021
Q1 | $560K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $657K | Buy |
|